Abstract
Despite major advances in blood purification therapies, numerous questions remain. As a result, clinicians may still have some hesitation regarding the real efficacy of these techniques in sepsis as well as the best mode of hemofiltration therapy when treating patients with septic shock plus acute kidney injury (AKI) [1]. However, despite major recent therapeutic improvements, septic shock remains a leading cause of mortality in intensive care patients [2]. In addition, according to the latest available literature, it is of paramount importance to realize that the mortality rate of patients with septic AKI is much higher compared to that of patients with non-septic AKI [3], [4]. In the last decade, several milestone studies [5], [6] have shown that dose of therapy is important in terms of mortality, although recent so-called negative trials have challenged this concept. Nevertheless, a critical dose is still desirable and beyond that dose, mortality will be affected [7], [8]. We should not forget, however, that these studies carry some very important limitations [9], [10]. Regarding specifically rationale, it seems at least theoretically reasonable that effectively removing mediators from the tissue, where they are harmful, and transporting them to the central circulation must be effective. Effectiveness through only a passive transportation mechanism remains elusive. Indeed, the surface of the central blood compartment is about 30 m2, which is much smaller than the surface of the capillary blood compartment, which is about 300 m2 [11], so that passive transport between these two asymmetric compartments will not yield the same elimination rate on both sides.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cerda J, Ronco C (2009) Modalities of continuous renal replacement therapy: technical and clinical considerations. Semin Dial 22: 114–122
Vincent JL, Atalan HK (2008) Epidemiology of severe sepsis in the intensive care unit. Br J Hosp Med 69: 442–443
Parmar A, Langenberg C, Wan L, May CN, Bellomo R, Bagshaw SM (2009) Epidemiology of septic acute kidney injury. Curr Drug Targets 10: 1169–1178
Chvojka J, Sykora R, Karvunidis T, et al (2011) New developments in septic acute kidney injury. Physiol Res (in press)
Ronco C, Bellomo R, Hornel P, et al (2000) Effect of different doses in continuous venovenous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 356: 26–30
Saudan P, Niederberger M, de Seigneux S, et al (2006) Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 70: 1312–1317
Palewsky PM, Zhang JH, O’Connor TZ, et al (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359: 7–20
Bellomo R, Cass A, Cole L, et al (2009) Intensity of continuous renal-replacement therapy in critically ill patients, N Engl J Med 361: 1627–1638
Ronco C, Cruz D, Oudemans van Straaten H, et al (2008) Dialysis dose in acute kidney injury: no time for therapeutic nihilism — a critical appraisal of the Acute Renal Failure Trial Network study. Crit Care 12:308
Ronco C, Honoré PM (2008) Renal support in critically ill patients with acute kidney injury. N Engl J Med 359: 1959–1962
Honoré PM, Joannes-Boyau O, Jacobs R, Solignac M (2010) Blood purification in sepsis: fiction or fact for the clinician. Reanimation 19: 7–12
Honoré PM, Zydney AL, Matson JR (2003) High volume and high permeability haemofiltration in sepsis. The evidences and the key issues. Care Crit Ill 3: 69–76
Ronco C, Bellomo R (2002) Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST). Int J Artif Organs 25: 733–747
Matson J R, Zydney AR, Honoré PM (2004) Blood filtration: New opportunities and the implications on system biology. Crit Care Resusc 6: 209–218
Di Carlo JV, Alexander SR (2005) Hemofiltration for cytokine-driven illness: the mediator delivery hypothesis. Int J Artif Organs 28: 777–786
Olszewski WL (2003) The lymphatic system in body homeostasis: physiological conditions. Lymph Fat Res Biol 1: 11–21
Onarherim H, Missavage E, Gunther RA, Kramer GC, Reed RK, Laurent TC (1991) Marked increase of plasma hyaluronan after major thermal injury and infusion therapy. J Surg Res 50: 259–65
Wasserman K, Mayerson HS (1952) Dynamics of lymph and plasma protein and exchange. Cardiologia 21: 296–307
Honoré PM, Joannes-Boyau 0, Boer W, Collin V (2009) High-volume hemofiltration in sepsis and SIRS: current concepts and future prospects. Blood Purif 28: 1–11
Honoré PM, Joannes-Boyau O (2004) High volume hemofiltration (HVHF) in sepsis: a comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Int J Artif Organs 27: 1077–1082
Dugernier T, Reynaert MS, Deby-Dupont G, et al (1989) Prospective evaluation of thoracic-duct drainage in the treatment of respiratory failure complicating severe acute pancreatitis. Intensive Care Med 15: 372–378
Mariano F, Cantaluppi V, Stella M, et al (2008) Circulating plasma factors induce tubular and glomerular alterations in septic burn patients. Crit Care 12: R42
Kellum JA, Song M, Venkataraman R (2004) Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med 32: 801–805
Honoré PM, Joannes-Boyau O, Boer W, Collin V, Jennes S (2009) Continuous haemofiltration in 2009: What’s new for clinicians regarding: Pathophysiology, technique to be privileged and dose to be recommended. Blood Purif 28: 135–143
Ronco C, Ricci Z, Bellomo R (2002) Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role for CVVH. EDTNA ERCA J 2: 13–18
Schiffl H, Lang SM, Fisher R (2002) Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346: 305–310
Honoré PM, Joannes-Boyau O, Collin V, Boer W, Gressens B, Janvier G (2008) [Practical daily management of extra-renal continuous removal]. Reanimation 17: 472–478
Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P (2001) High-volume haemofiltration in human septic shock. Intensive Care Med 27: 978–986
Ratanarat R, Brendolan A, Piccinni P, et al (2005) Pulse-high volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 9: 294–302
Piccinni P, Dan M, Barbacini S, et al (2006) Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 32: 80–86
Cornejo R, Downey P, Castro R, et al (2006) High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 32: 713–722
Bell M, SWING, Granath F, Schon S, Ekbom A, Martling CR (2007) Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure. Intensive Care Med 33: 773–780
Ridel C, Balde MC, Rondeau E, Vinsonneau C (2009) Dose of dialysis in intensive care unit. Reanimation 18: 385–396
Payen D, Mateo J, Cavaillon JM, Fraisse F, Floriot C, Vicaut E (2009) Hemofiltration and Sepsis Group of the Collège National de Réanimation et de Médecine d’Urgence des Hôpitaux extra-Universitaires. Impact of continuous veno-venous hemofiltration on organ failure during the early phase of severe sepsis: A randomized controlled trial. Crit Care Med 37: 803–810
Joannes-Boyau O, Honoré PM, Boer W, Collin V (2009) Are the synergistic effects of high-volume haemofiltration and enhanced adsorption the missing key in sepsis modulation? Nephrol Dial transplant 24: 354–357
Prowle JR, Bellomo R (2010) Continuous renal replacement therapy: recent advances and future research. Nature Rev Nephrol 6: 521–529
Morgera S, Haase M, Kuss T, et al (2006) Pilot study on the effects of high cutoff hemofil-tration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med 34: 2099–2104
Honoré PM (2009) Novel therapeutical concepts for extracorporeal treatment of hyperin-flammation and sepsis: immunomodulation approach with a novel high cut-off membrane:The SepteX membrane. Proceedings of the 10th WFSCICCM, Florence, S10–S12 (abst)
Uchino S, Bellomo R, Goldsmith D, et al (2002) Super high flux hemofiltration: a new technique for cytokine removal. Intensive Care Med 28: 651–655
Joannes-Boyau O, Honoré PM (2010) Haemofiltration Study: IVOIRE (high VOlume in Intensive Care). Available at: http://clinicaltrials.gov/ct2/show/NCT00241228?term=ivoire&rank = 1. Accessed Nov 2010
Bellomo R, Palevsky P, Bagshaw S, et al (2010) Recent trials in critical care nephrology. Contrib Nephrol 166: 299–309
Bellomo R, Ronco C, Kellum J, Mehta R, Palevsky P, and the ADQI workgroup (2004) Acute renal failure — definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8: 204–212
Honoré PM, Jamez J, Wauthier M, et al (2000) Prospective evaluation of short term high volume isovolemic haemofiltration on the haemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28: 3581–3587
Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Janvier G (2004) Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 50: 102–109
Cruz DN, Antonelli M, Fumagalli R, et al (2009) Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial JAMA 301: 2445–2452
Vesconi R, Cruz DN, Fumagalli R et al (2009) Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care 13: R57
Honoré PM, Joannes-Boyau O, Boer W, Rose T (2010) Real time non-invasive follow-up of acid-base correction by the kidney: A step closer. Minerva Anestesiol 76: 307–309
Joannes-Boyau O, Honoré PM, Boer W, Rose T (2010) Septic acute kidney injury and inflammatory apoptosis: never a lone ranger. Intensive Care Med 36: 385–388
Honoré PM, Jacobs R, Boer W, Joannes-Boyau O (2011) Sepsis and AKI: more complex than just a simple question of Chicken and Egg. Intensive Care Med (in press)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media LLC
About this chapter
Cite this chapter
Honoré, P.M., Dobbeleire, N., Joannes-Boyau, O. (2011). Blood Purification in Sepsis and Acute Kidney Injury in Critically III Patients. In: Vincent, JL. (eds) Annual Update in Intensive Care and Emergency Medicine 2011. Annual Update in Intensive Care and Emergency Medicine 2011, vol 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18081-1_24
Download citation
DOI: https://doi.org/10.1007/978-3-642-18081-1_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-18080-4
Online ISBN: 978-3-642-18081-1
eBook Packages: MedicineMedicine (R0)